Report Detail

Pharma & Healthcare Global Substance Abuse Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • RnM3787076
  • |
  • 27 September, 2019
  • |
  • Global
  • |
  • 121 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Substance Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of substance abuse. Some commonly used drug for treatment of substance abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.

Scope of the Report:
The global Substance Abuse Therapeutics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Substance Abuse Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Substance Abuse Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Substance Abuse Therapeutics market by product type and applications/end industries.

Market Segment by Companies, this report covers
Indivior
Pfizer
Alkermes
Novartis
Mylan
Cipla
Glenmark
Dr. Reddy's Laboratories
Teva Pharmaceutical

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Opioid Addiction
Tobacco/Nicotine Addiction
Alcohol Dependence

Market Segment by Applications, can be divided into
Hospital & Clinics
Residential (non-hospital)


Table of Contents

    1 Substance Abuse Therapeutics Market Overview

    • 1.1 Product Overview and Scope of Substance Abuse Therapeutics
    • 1.2 Classification of Substance Abuse Therapeutics by Types
      • 1.2.1 Global Substance Abuse Therapeutics Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Substance Abuse Therapeutics Revenue Market Share by Types in 2018
      • 1.2.3 Opioid Addiction
      • 1.2.4 Tobacco/Nicotine Addiction
      • 1.2.5 Alcohol Dependence
    • 1.3 Global Substance Abuse Therapeutics Market by Application
      • 1.3.1 Global Substance Abuse Therapeutics Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Hospital & Clinics
      • 1.3.3 Residential (non-hospital)
    • 1.4 Global Substance Abuse Therapeutics Market by Regions
      • 1.4.1 Global Substance Abuse Therapeutics Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Substance Abuse Therapeutics Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Substance Abuse Therapeutics Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Substance Abuse Therapeutics Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Substance Abuse Therapeutics Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Substance Abuse Therapeutics Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Substance Abuse Therapeutics (2014-2024)

    2 Manufacturers Profiles

    • 2.1 Indivior
      • 2.1.1 Business Overview
      • 2.1.2 Substance Abuse Therapeutics Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Indivior Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Pfizer
      • 2.2.1 Business Overview
      • 2.2.2 Substance Abuse Therapeutics Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Pfizer Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Alkermes
      • 2.3.1 Business Overview
      • 2.3.2 Substance Abuse Therapeutics Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Alkermes Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Novartis
      • 2.4.1 Business Overview
      • 2.4.2 Substance Abuse Therapeutics Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Novartis Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Mylan
      • 2.5.1 Business Overview
      • 2.5.2 Substance Abuse Therapeutics Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Mylan Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Cipla
      • 2.6.1 Business Overview
      • 2.6.2 Substance Abuse Therapeutics Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Cipla Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Glenmark
      • 2.7.1 Business Overview
      • 2.7.2 Substance Abuse Therapeutics Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Glenmark Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Dr. Reddy's Laboratories
      • 2.8.1 Business Overview
      • 2.8.2 Substance Abuse Therapeutics Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Dr. Reddy's Laboratories Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Teva Pharmaceutical
      • 2.9.1 Business Overview
      • 2.9.2 Substance Abuse Therapeutics Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Teva Pharmaceutical Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Substance Abuse Therapeutics Market Competition, by Players

    • 3.1 Global Substance Abuse Therapeutics Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Substance Abuse Therapeutics Players Market Share
      • 3.2.2 Top 10 Substance Abuse Therapeutics Players Market Share
    • 3.3 Market Competition Trend

    4 Global Substance Abuse Therapeutics Market Size by Regions

    • 4.1 Global Substance Abuse Therapeutics Revenue and Market Share by Regions
    • 4.2 North America Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
    • 4.5 South America Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)

    5 North America Substance Abuse Therapeutics Revenue by Countries

    • 5.1 North America Substance Abuse Therapeutics Revenue by Countries (2014-2019)
    • 5.2 USA Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)

    6 Europe Substance Abuse Therapeutics Revenue by Countries

    • 6.1 Europe Substance Abuse Therapeutics Revenue by Countries (2014-2019)
    • 6.2 Germany Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
    • 6.3 UK Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
    • 6.4 France Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Substance Abuse Therapeutics Revenue by Countries

    • 7.1 Asia-Pacific Substance Abuse Therapeutics Revenue by Countries (2014-2019)
    • 7.2 China Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
    • 7.5 India Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)

    8 South America Substance Abuse Therapeutics Revenue by Countries

    • 8.1 South America Substance Abuse Therapeutics Revenue by Countries (2014-2019)
    • 8.2 Brazil Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Substance Abuse Therapeutics by Countries

    • 9.1 Middle East and Africa Substance Abuse Therapeutics Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)

    10 Global Substance Abuse Therapeutics Market Segment by Type

    • 10.1 Global Substance Abuse Therapeutics Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Substance Abuse Therapeutics Market Forecast by Type (2019-2024)
    • 10.3 Opioid Addiction Revenue Growth Rate (2014-2024)
    • 10.4 Tobacco/Nicotine Addiction Revenue Growth Rate (2014-2024)
    • 10.5 Alcohol Dependence Revenue Growth Rate (2014-2024)

    11 Global Substance Abuse Therapeutics Market Segment by Application

    • 11.1 Global Substance Abuse Therapeutics Revenue Market Share by Application (2014-2019)
    • 11.2 Substance Abuse Therapeutics Market Forecast by Application (2019-2024)
    • 11.3 Hospital & Clinics Revenue Growth (2014-2019)
    • 11.4 Residential (non-hospital) Revenue Growth (2014-2019)

    12 Global Substance Abuse Therapeutics Market Size Forecast (2019-2024)

    • 12.1 Global Substance Abuse Therapeutics Market Size Forecast (2019-2024)
    • 12.2 Global Substance Abuse Therapeutics Market Forecast by Regions (2019-2024)
    • 12.3 North America Substance Abuse Therapeutics Revenue Market Forecast (2019-2024)
    • 12.4 Europe Substance Abuse Therapeutics Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Substance Abuse Therapeutics Revenue Market Forecast (2019-2024)
    • 12.6 South America Substance Abuse Therapeutics Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Substance Abuse Therapeutics Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Summary:
      Get latest Market Research Reports on Substance Abuse Therapeutics. Industry analysis & Market Report on Substance Abuse Therapeutics is a syndicated market report, published as Global Substance Abuse Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Substance Abuse Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,770.08
      4,155.12
      5,540.16
      3,232.92
      4,849.38
      6,465.84
      535,711.20
      803,566.80
      1,071,422.40
      290,614.80
      435,922.20
      581,229.60
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report